Clinical Trials Logo

Filter by:
NCT ID: NCT06421909 Recruiting - Menopause Clinical Trials

Mindfulness-based Educational Intervention on Anxiety, Depression, Stress and Quality of Life on Menopausal Woman

mindmenopaus
Start date: April 18, 2024
Phase: N/A
Study type: Interventional

Mindfulness-based educational intervention is a structured program that incorporates principles of mindfulness to help individuals develop greater awareness and acceptance of their thoughts, feelings, and bodily sensations. The intervention typically includes mindfulness meditation practices, cognitive-behavioral techniques, and educational components about stress management and emotional regulation. By fostering a non-judgmental and present-focused attitude, participants learn to manage their symptoms more effectively and improve their overall quality of life.

NCT ID: NCT06424613 Recruiting - Bipolar Disorder Clinical Trials

Effects of Lithium on Suicide Prevention in Adolescents and Young Adults With Bipolar Disorder in China

Start date: April 18, 2024
Phase:
Study type: Observational

This study aims to use a retrospective cohort approach to explore the impact of lithium carbonate on suicide and self-harm related events among adolescents and young adults with bipolar disorder in China.The primary objective of this study is to investigate the effects of lithium carbonate on suicidal ideation in adolescents and young adults with bipolar disorder in China. Secondary objectives include exploring its effects on preventing suicide attempts, non-suicidal self-injury, and aggressive behaviors in this population.

NCT ID: NCT06431529 Recruiting - Tumor, Solid Clinical Trials

A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors

Neoantigen-T
Start date: April 18, 2024
Phase: Early Phase 1
Study type: Interventional

The goal of this clinical trial is to learn if tumor neoantigen-specific T cells can treat patients with advanced solid tumors. The main questions it aims to answer are: Evaluate the safety of intravenous infusion of tumor neoantigen-specific T cells in the treatment of advanced solid tumors such as ovarian cancer, non-small cell lung cancer, and colorectal cancer. To evaluate the effectiveness of intravenous infusion of tumor neoantigen-specific T cells in the treatment of advanced solid tumors such as ovarian cancer, non-small cell lung cancer, and colorectal cancer and to study its immunological properties in patients.

NCT ID: NCT02622438 Recruiting - Clinical trials for Primary Disease Fascioscapulohumeral Dystrophy (FSHD)

Routine Health Care of Patients With FSHD

FSHD
Start date: April 19, 2015
Phase: N/A
Study type: Interventional

On the basis of published data and our results indicating that oxidative stress may contribute to the peripheral skeletal muscle dysfunction in patients with FSHD, investigators conducted a pilot randomized double-blind placebo controlled trial to test whether oral administration of vitamins and mineral could improve the physical performance of patients with FSHD.The result of this clinical trial showed that antioxidants supplementation may improve skeletal muscle function of patients with FSHD and suggest that an antioxidant strategy adapted may be a relevant therapeutic approach for these patients. Since then, patients with FSHD who attend consultation at Montpellier hospital are systematically supplemented with antioxidants according their own blood tests.

NCT ID: NCT03278652 Recruiting - Renal Colic Clinical Trials

Use of Analgesic Drugs in Renal Colic in Emergency Room

NEPHROPAIN
Start date: April 19, 2016
Phase: N/A
Study type: Observational

A prospective non-interventional study on the use of analgesic drugs in renal colic in emergency rooms

NCT ID: NCT02898818 Recruiting - Healthy Clinical Trials

Vaginal and Oral Microbiome Crosstalk

Start date: April 19, 2017
Phase:
Study type: Observational [Patient Registry]

To study the vaginal and oral microbiome by swab samples. On selected cases, also papa smear will be studied.

NCT ID: NCT02962830 Recruiting - Prenatal Diagnosis Clinical Trials

Sufentanil Pharmacokinetics After Intra Amniotic Injection

2IAS
Start date: April 19, 2017
Phase: Phase 2
Study type: Interventional

The fetus may be exposed during pregnancy to nociceptive stimuli because of fetal pathology (e.g., malformation) or a diagnostic or therapeutic procedure. To date, there is very little data and no consensus on fetal analgesia. The aim of the investigators study is to evaluate the pharmacokinetics of Sufentanil after intra amniotic injection.

NCT ID: NCT03076554 Recruiting - Thymoma Clinical Trials

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

Start date: April 19, 2017
Phase: Phase 2
Study type: Interventional

Background: Thymoma and thymic carcinoma are cancers originating in the thymus gland. Platinum-based chemotherapy is standard treatment for them. But not uncommonly, the disease returns and people need more treatment to keep the cancer from growing. The drug Avelumab could help the immune system fight cancer. Objective: To test if avelumab is safe and well-tolerated, and is effective in treating relapsed or refractory thymoma and thymic carcinoma. Eligibility: People ages 18 and older with thymoma or thymic carcinoma that has returned or progressed after platinum-containing chemotherapy Design: Participants will be screened with: - Blood, urine, and heart tests - Scan: They lie in a machine that takes pictures of the body. - Physical exam - Medical history - Biopsy: a needle removes a piece of tumor. Samples can be from a previous procedure, although it is desirable to undergo a new biopsy. Participants will have treatment in 2-week cycles. They will continue until the side effects are not tolerable or their disease gets worse. Visits at the following time points are required per protocol. Patients who respond to treatment or have durable stability after at least 12 months of therapy may undergo a dose de-escalation regimen to continue on therapy. - Every 2 weeks: Participants will get avelumab by infusion in a vein (IV). They will get diphenhydramine (benadryl) and acetaminophen (tylenol) by mouth or IV before receiving avelumab to decrease the chances of developing a reaction to avelumab. They will have blood, urine, and heart tests periodically. - Cycles 4 and 7, then every 6 weeks: Scans will be performed to look for shrinkage or growth of tumor. - Cycle 4: Participants will be offered a chance to undergo a biopsy. - 2-4 weeks after stopping treatment: Blood, urine, and heart tests will be performed. Participants might undergo a scan. - 10 weeks after stopping treatment: Blood, urine, and heart tests. - About 6 months after stopping treatment, then every 3 months: Participants will have scans andcan allow genetic testing on their blood and tissue samples.

NCT ID: NCT03146676 Recruiting - Clinical trials for Hidradenitis Suppurativa

The Ohio State University Dermatology Biorepository

Start date: April 19, 2017
Phase:
Study type: Observational

This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.

NCT ID: NCT03157206 Recruiting - Clinical trials for Diabetic Macular Edema

Diabetic Retinopathy Assessed by Ultra-wide

REGARD1
Start date: April 19, 2017
Phase: N/A
Study type: Observational

Patients with diabetic macular edema treated with aflibercept injections for visual impairment will be observed in standard care during 12 months. They will undergo visual assessments by Ultrawide Field angiography at baseline and at 12 months